[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Recombinant Protein Drugs Market Report 2017

January 2018 | 114 pages | ID: AF7E409894AEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Recombinant Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Recombinant Protein Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Recombinant Protein Drugs market competition by top manufacturers/players, with Recombinant Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novo Nordisk
  • Amgen
  • Sanofi
  • Eli Lilly
  • Merck Serono
  • Ortho Biotech
  • Roche
  • Kyowa Hakko Kirin
  • Pharmingen
  • Abcam
  • GenSci
  • SL PHARM
  • Dongbao Pharm
  • Ankebio
  • NCPC
  • Heng Rui
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Recombinant DNA
  • Recombinant RNA
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Pharmaceutical Industry
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Recombinant Protein Drugs Market Report 2017

1 RECOMBINANT PROTEIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs by Product Category
  1.2.1 Asia-Pacific Recombinant Protein Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Recombinant Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Recombinant DNA
  1.2.4 Recombinant RNA
1.3 Asia-Pacific Recombinant Protein Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Recombinant Protein Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Pharmaceutical Industry
  1.3.3 Other
1.4 Asia-Pacific Recombinant Protein Drugs Market by Region
  1.4.1 Asia-Pacific Recombinant Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Recombinant Protein Drugs (2012-2022)
  1.5.1 Asia-Pacific Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC RECOMBINANT PROTEIN DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Recombinant Protein Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Recombinant Protein Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Recombinant Protein Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Recombinant Protein Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Recombinant Protein Drugs (Volume) by Application
2.4 Asia-Pacific Recombinant Protein Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Recombinant Protein Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Recombinant Protein Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Recombinant Protein Drugs Sales and Value (2012-2017)
  3.1.1 China Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Recombinant Protein Drugs Sales Price Trend (2012-2017)
3.2 China Recombinant Protein Drugs Sales Volume and Market Share by Type
3.3 China Recombinant Protein Drugs Sales Volume and Market Share by Application

4 JAPAN RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Recombinant Protein Drugs Sales and Value (2012-2017)
  4.1.1 Japan Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Recombinant Protein Drugs Sales Price Trend (2012-2017)
4.2 Japan Recombinant Protein Drugs Sales Volume and Market Share by Type
4.3 Japan Recombinant Protein Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Recombinant Protein Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Recombinant Protein Drugs Sales Price Trend (2012-2017)
5.2 South Korea Recombinant Protein Drugs Sales Volume and Market Share by Type
5.3 South Korea Recombinant Protein Drugs Sales Volume and Market Share by Application

6 TAIWAN RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Recombinant Protein Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Recombinant Protein Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Recombinant Protein Drugs Sales Volume and Market Share by Type
6.3 Taiwan Recombinant Protein Drugs Sales Volume and Market Share by Application

7 INDIA RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Recombinant Protein Drugs Sales and Value (2012-2017)
  7.1.1 India Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Recombinant Protein Drugs Sales Price Trend (2012-2017)
7.2 India Recombinant Protein Drugs Sales Volume and Market Share by Type
7.3 India Recombinant Protein Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Recombinant Protein Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Recombinant Protein Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Recombinant Protein Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Recombinant Protein Drugs Sales Volume and Market Share by Application

9 AUSTRALIA RECOMBINANT PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Recombinant Protein Drugs Sales and Value (2012-2017)
  9.1.1 Australia Recombinant Protein Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Recombinant Protein Drugs Sales Price Trend (2012-2017)
9.2 Australia Recombinant Protein Drugs Sales Volume and Market Share by Type
9.3 Australia Recombinant Protein Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC RECOMBINANT PROTEIN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Novo Nordisk
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Amgen
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Sanofi
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Eli Lilly
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Merck Serono
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Ortho Biotech
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Roche
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Kyowa Hakko Kirin
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Pharmingen
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Abcam
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Recombinant Protein Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 GenSci
10.12 SL PHARM
10.13 Dongbao Pharm
10.14 Ankebio
10.15 NCPC
10.16 Heng Rui

11 RECOMBINANT PROTEIN DRUGS MANUFACTURING COST ANALYSIS

11.1 Recombinant Protein Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Recombinant Protein Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Recombinant Protein Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC RECOMBINANT PROTEIN DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Recombinant Protein Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Recombinant Protein Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Recombinant Protein Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Recombinant Protein Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Recombinant Protein Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Recombinant Protein Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Recombinant Protein Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Recombinant Protein Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Recombinant Protein Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Recombinant Protein Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Recombinant Protein Drugs
Figure Asia-Pacific Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2022)
Figure Asia-Pacific Recombinant Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant DNA Product Picture
Figure Recombinant RNA Product Picture
Figure Asia-Pacific Recombinant Protein Drugs Sales (K Doses) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Recombinant Protein Drugs by Application in 2016
Figure Pharmaceutical Industry Examples
Table Key Downstream Customer in Pharmaceutical Industry
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Recombinant Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate (2012-2022)
Figure Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Recombinant Protein Drugs Market Major Players Product Sales Volume (K Doses)(2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Recombinant Protein Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Recombinant Protein Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Recombinant Protein Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Recombinant Protein Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Recombinant Protein Drugs Revenue Share by Players
Table Asia-Pacific Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Recombinant Protein Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Recombinant Protein Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Sales Volume (K Doses) and Market Share by Region (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Region (2012-2017)
Figure Asia-Pacific Recombinant Protein Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Region (2012-2017)
Figure Asia-Pacific Recombinant Protein Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Recombinant Protein Drugs Sales Volume (K Doses) and Market Share by Application (2012-2017)
Table Asia-Pacific Recombinant Protein Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Recombinant Protein Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Recombinant Protein Drugs Sales Market Share by Application (2012-2017)
Figure China Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table China Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table China Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table China Recombinant Protein Drugs Sales Volume (K Doses) by Applications (2012-2017)
Table China Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Figure Japan Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table Japan Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table Japan Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table Japan Recombinant Protein Drugs Sales Volume (K Doses) by Applications (2012-2017)
Table Japan Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure South Korea Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table South Korea Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table South Korea Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table South Korea Recombinant Protein Drugs Sales Volume (K Doses) by Applications (2012-2017)
Table South Korea Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Taiwan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table Taiwan Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table Taiwan Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Recombinant Protein Drugs Sales Volume (K Doses) by Applications (2012-2017)
Table Taiwan Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Figure India Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table India Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table India Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table India Recombinant Protein Drugs Sales Volume (K Doses) by Application (2012-2017)
Table India Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Recombinant Protein Drugs Sales Volume (K Doses) by Applications (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Figure Australia Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Australia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2012-2017)
Table Australia Recombinant Protein Drugs Sales Volume (K Doses) by Type (2012-2017)
Table Australia Recombinant Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Recombinant Protein Drugs Sales Volume Market Share by Type in 2016
Table Australia Recombinant Protein Drugs Sales Volume (K Doses) by Applications (2012-2017)
Table Australia Recombinant Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Recombinant Protein Drugs Sales Volume Market Share by Application in 2016
Table Novo Nordisk Recombinant Protein Drugs Basic Information List
Table Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Recombinant Protein Drugs Basic Information List
Table Amgen Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Amgen Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Amgen Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Recombinant Protein Drugs Basic Information List
Table Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Sanofi Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly Recombinant Protein Drugs Basic Information List
Table Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Eli Lilly Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Eli Lilly Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Serono Recombinant Protein Drugs Basic Information List
Table Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck Serono Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Merck Serono Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Serono Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Ortho Biotech Recombinant Protein Drugs Basic Information List
Table Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Ortho Biotech Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Ortho Biotech Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Ortho Biotech Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Recombinant Protein Drugs Basic Information List
Table Roche Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Roche Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Roche Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Kyowa Hakko Kirin Recombinant Protein Drugs Basic Information List
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Pharmingen Recombinant Protein Drugs Basic Information List
Table Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Pharmingen Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Pharmingen Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pharmingen Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Abcam Recombinant Protein Drugs Basic Information List
Table Abcam Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Abcam Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2012-2017)
Figure Abcam Recombinant Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Abcam Recombinant Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table GenSci Recombinant Protein Drugs Basic Information List
Table SL PHARM Recombinant Protein Drugs Basic Information List
Table Dongbao Pharm Recombinant Protein Drugs Basic Information List
Table Ankebio Recombinant Protein Drugs Basic Information List
Table NCPC Recombinant Protein Drugs Basic Information List
Table Heng Rui Recombinant Protein Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Dose) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2016
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure Asia-Pacific Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Price (USD/Dose) and Trend Forecast (2017-2022)
Table Asia-Pacific Recombinant Protein Drugs Sales Volume (K Doses) Forecast by Region (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Revenue Market Share Forecast by Region in 2022
Figure China Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure South Korea Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Taiwan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Recombinant Protein Drugs Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Australia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Recombinant Protein Drugs Sales (K Doses) Forecast by Type (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Recombinant Protein Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Recombinant Protein Drugs Price (USD/Dose) Forecast by Type (2017-2022)
Table Asia-Pacific Recombinant Protein Drugs Sales (K Doses) Forecast by Application (2017-2022)
Figure Asia-Pacific Recombinant Protein Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories